Results for this period
Interim period (second quarter)1 April 2026–30 September 2026Non-consolidated (individual)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Although demand is recovering, including from inbound tourism, raw material and energy prices, procurement and logistics costs, and recruitment and personnel costs remain high. The company worked on revising selling prices, developing and renewing products, consignment sales including home-delivery medicines, expanding store private-label products and cross-selling, and selling summer products and products addressing heatstroke prevention. In the bottled-water business, the core 12-liter bottles remained firm, but sales of water-related products fell below the same period of the previous year.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (individual) |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥3,362 million (YoY +1.2%) |
| Operating profit | ¥22 million (YoY -30.3%) |
| Ordinary income | ¥25 million (YoY -38.0%) |
| Profit attributable to owners of the parent | ¥10 million (YoY -63.8%) |
| Net income per share | ¥0.96 |
| Equity ratio | End of the current fiscal period 47.2 / End of previous period 48.8 |
| Total assets | ¥5,484 million |
| Net assets | ¥2,588 million |
| Cash flows from operating activities | ¥-91,656 thousand |
| Cash flows from investing activities | ¥103,149 thousand |
| Cash flows from financing activities | ¥171,122 thousand |
| Cash and cash equivalents at end of period | ¥1,139,328 thousand |
| Full-year earnings forecast | Net Sales ¥6,150 million (YoY -6.4%) / Operating profit ¥133 million (YoY +4.4%) / Ordinary income ¥145 million (YoY +3.8%) / Net income ¥85 million (YoY +2.3%) |
| Revision to Earnings Forecast | No revision → No revision |
| Annual Dividend Forecast | ¥5 → ¥5（0.0%） |
| Segment revenue | Household medicines and related products sales business ¥2,976 million (YoY +2.1%), Water sales business ¥386 million (YoY -4.9%) |
| Segment profit | Household medicines and related products sales business ¥-29 million, Water sales business ¥51 million (YoY -13.7%) |
| Depreciation and amortization | ¥22,926 thousand |
| Impairment loss | Not applicable (information on impairment losses on fixed assets by reporting segment) |
| Breakdown of extraordinary income (loss) | Extraordinary income None / Extraordinary loss Loss on redemption of investment securities ¥38 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Material subsequent events | The company resolved to acquire, through a business transfer, customers held in certain regions by 前花薬品株式会社 and entered into a business transfer agreement on 30 October 2026. The business combination date is 1 January 2027, and the acquisition cost and other details have not been disclosed or are still being calculated. |
| Availability of Supplementary Financial Results Materials | None |
| Availability of Financial Results Briefing | None |
| Issued Shares at Period-End | 11,660,734 |
| Treasury Shares at Period-End | 970,415 |
| Factors Behind Changes in Business Performance | Although demand is recovering, including from inbound tourism, raw material and energy prices, procurement and logistics costs, and recruitment and personnel costs remain high. The company worked on revising selling prices, developing and renewing products, consignment sales including home-delivery medicines, expanding store private-label products and cross-selling, and selling summer products and products addressing heatstroke prevention. In the bottled-water business, the core 12-liter bottles remained firm, but sales of water-related products fell below the same period of the previous year. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that it faced a challenging cost environment, including persistently high raw material and energy prices amid unstable currency movements, higher logistics costs and increased personnel expenses. It attributed the decline in interim net profit to the recognition of ¥11 million in adjustments to corporate income taxes and other taxes.